AMRN Q1 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73M+66.8% YoY

Gross Profit

$56M76.6% margin

Operating Income

-$23M-31.0% margin

Net Income

-$24M-33.3% margin

EPS (Diluted)

$-1.49

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$372M

Total Liabilities

$231M

Stockholders' Equity

$141M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$44M	+66.8%
Gross Profit	$56M	$33M	+68.7%
Operating Income	-$23M	-$22M	-3.8%
Net Income	-$24M	-$24M	-1.4%

Revenue Segments

Product

$73M99%

License

$547,0001%